Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites. - Qian, Ciying; Chen, Jie; Yang, Yurou; Lu, Yihan; Ren, Tianyu; Jiang, Yanan; Huang, Yang; Chi, Xin; Zhang, Shuyue; Zhang, Chengzong; Li, Kewei; Shen, Jingjia; et al. (Journal of Nanobiotechnology, 2025)